Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...

Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can ...

I am sure that many of my readers have no idea what 'Slinding Cupping Therapy' is. It is a TCM therapy that, according to the authors of this paper, receives much appreciation for treating plaque ...

Objectives This study aims to estimate the prevalence of long-lasting severe fatigue and identify possible risk factors in a ...

Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel ...

Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for ...

Doulas provide emotional, physical, and informational support during pregnancy, labor, and the postpartum period.

A recent study published in Progress in Neuro-Psychopharmacology and Biological Psychiatry sheds light on how psilocybin ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children and adults.